NASDAQ · Drug Manufacturers - Specialty & Generic

Harrow, Inc. (HROW) Stock

$28.44 +1.03% NASDAQ: HROW Healthcare

Valuation

MetricValue
Price$28.44
Market Cap$1.07B
P/E Ratio-30.94
P/B Ratio75.46
P/S Ratio4.15
EPS (TTM)$2.72
52-Week High$54.85
52-Week Low$27.24
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-103.86%
ROA-8.93%
ROCE1.81%
Gross Margin74.11%
Operating Margin10.47%
Net Margin-13.51%
Debt/Equity19.79
Current Ratio2.21

Annual Financials (USD)

Metric20212022202320242025
Revenue$72.0M$89.0M$130.0M$200.0M$272.0M
Operating Profit$2.0M$2.0M$0$9.0M$39.0M
Net Profit$-18.0M$-14.0M$-24.0M$-17.0M$-5.0M
EPS$-0.69$-0.51$-0.75$-0.49$-0.14
Op Margin2.2%2.2%0.3%4.4%14.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$98.0M$157.0M$312.0M$389.0M$399.0M
Total Liabilities$87.0M$130.0M$242.0M$320.0M$347.0M
Cash$42.0M$96.0M$74.0M$47.0M$73.0M
Borrowings$78.0M$112.0M$191.0M$229.0M$252.0M

Latest News

Harrow Expands Retina Portfolio With US Launch of Byooviz MT Newswires · Jul 1, 2026 Harrow Announces Commercial Launch of BYOOVIZ® in the United States GlobeNewswire · Jul 1, 2026 Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow Business Wire · Jul 1, 2026 GROW Small Cap Equity Fund Covered Its Position in Harrow (HROW) in Q1 Insider Monkey · Jun 23, 2026 Is Harrow, Inc. (HROW) A Good Stock To Buy Now? Insider Monkey · Jun 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$5.0M$2.0M$4.0M$-22.0M$44.0M
Investing Cash Flow$-47.0M$-10.0M$-305.0M$-72.0M$-7.0M
Financing Cash Flow$-19.0M$0$-13.0M$-2.0M$-25.0M
Net Cash Flow$38.0M$54.0M$-22.0M$-27.0M$26.0M
Free Cash Flow$-23.0M$-6.0M$-149.0M$-61.0M$43.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.57
EV / EBITDA303.72
FCF Yield0.50%
Quick Ratio2.08
Interest Coverage0.25
Return 1Y13.40%
Return 3Y97.08%
Return 5Y407.26%

About Harrow, Inc.

Harrow, Inc. is led by CEO Mark L. Baum, employs 382 people, headquartered in US, publicly traded since 2007.

Harrow, Inc. (HROW) stock trades at $28.44 with a market capitalization of $1.07B. The stock is valued at a negative price-to-earnings (P/E) ratio of -30.94, reflecting a net loss over the last twelve months, price-to-book of 75.46, price-to-sales of 4.15. Over the past 52 weeks the stock has ranged between $27.24 and $54.85, and currently trades 48.1% below its 52-week high.

On profitability, Harrow, Inc. generates a return on equity (ROE) of -103.86% (negative, reflecting a net loss), return on capital employed of 1.81%, an operating margin of 10.47%, a net profit margin of -13.51%.

Harrow, Inc. by the numbers, 2016–2025

Between 2016 and 2025 Harrow, Inc. reported revenue of $20.0M rising to $272.0M, a change of +1260.0% across 10 years. Compounded, revenue has grown 40.9% a year over five years, 45.1% over three, 36.0% over the last twelve months. Net profit rose to $-5.0M.

Operating margin went from -79.6% in 2016 to 14.2% in 2025, a gain of 93.8 percentage points. The most recent net margin is -13.51%. On a trailing twelve-month basis to Jun '26, revenue is $276.0M and net profit $-37.0M.

Borrowings rose from $14.0M to $252.0M, cash from operations was $44.0M in the latest year, positive in 6 of the last 10.

Return on equity has averaged -56.4% over five years, and was -9.6% in the most recent year.

The share price itself has compounded at 36.0% a year over five years, 27.6% over three, 28.1% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Harrow, Inc. (HROW) — frequently asked questions

What is Harrow, Inc. (HROW) stock price today?

Harrow, Inc. (HROW) is currently trading at $28.44, up 1.03% today.

What is HROW P/E ratio?

Harrow, Inc.'s P/E ratio is -30.94. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is HROW return on equity (ROE)?

Harrow, Inc.'s return on equity (ROE) is -103.86%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Harrow, Inc.'s market cap?

Harrow, Inc. has a market capitalization of $1.07B.

Does HROW pay a dividend?

Harrow, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does HROW carry?

Harrow, Inc. has a debt-to-equity ratio of 19.79. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is HROW's profit margin?

Harrow, Inc. reports a net profit margin of -13.51% — the share of revenue left after every cost, including tax and interest.

What sector is HROW in?

Harrow, Inc. is classified under Healthcare, in the Drug Manufacturers - Specialty & Generic industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is HROW listed on?

Harrow, Inc. trades on NASDAQ under the ticker HROW.

What is HROW's 52-week range?

Over the last year Harrow, Inc. has traded between $27.24 and $54.85.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens HROW currently matches

On the figures above, Harrow, Inc. passes the filters for 7 of our ready-made screens, among them Small Cap Stocks, Most Shorted Stocks, High Debt to Equity Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Small Cap StocksMost Shorted StocksHigh Debt to Equity StocksStocks Under $100Stocks Under $50High Gross Margin StocksHigh Current Ratio Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.